8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride

C23H20Br2ClN3 — CID 162319307

IUPAC8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride
SMILESCN1CCN=C(/C=C/c2cnccc2-c2cccc(Br)c2)c2ccc(Br)cc21.Cl
InChIInChI=1S/C23H19Br2N3.ClH/c1-28-12-11-27-22(21-7-6-19(25)14-23(21)28)8-5-17-15-26-10-9-20(17)16-3-2-4-18(24)13-16;/h2-10,13-15H,11-12H2,1H3;1H/b8-5+;
InChIKeyLORZGFLJIGXHRP-HAAWTFQLSA-N
MW533.70 g/mol
LogP6.65
Rot. Bonds3

About 8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride

8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride (PubChem CID 162319307) has the molecular formula C23H20Br2ClN3 and a molecular weight of 533.70 g/mol. Its IUPAC name is 8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride.

Molecular Properties

Compound Name8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride
PubChem CID162319307
Molecular FormulaC23H20Br2ClN3
Molecular Weight533.70 g/mol
Exact Mass530.97
IUPAC Name8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride
SMILESCN1CCN=C(/C=C/c2cnccc2-c2cccc(Br)c2)c2ccc(Br)cc21.Cl
InChIInChI=1S/C23H19Br2N3.ClH/c1-28-12-11-27-22(21-7-6-19(25)14-23(21)28)8-5-17-15-26-10-9-20(17)16-3-2-4-18(24)13-16;/h2-10,13-15H,11-12H2,1H3;1H/b8-5+;
InChIKeyLORZGFLJIGXHRP-HAAWTFQLSA-N
XLogP6.65
TPSA28.49 Ų
H-Bond Donors
H-Bond Acceptors3
Rotatable Bonds3
Heavy Atoms29
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500533.70
LogP ≤ 56.65
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 103

Analyze 8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride?
The IUPAC name of 8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride (CID 162319307) is 8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride.
What is the SMILES notation for 8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride?
The canonical SMILES for 8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride is CN1CCN=C(/C=C/c2cnccc2-c2cccc(Br)c2)c2ccc(Br)cc21.Cl.
What is the InChIKey of 8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride?
The InChIKey is LORZGFLJIGXHRP-HAAWTFQLSA-N. The full InChI is InChI=1S/C23H19Br2N3.ClH/c1-28-12-11-27-22(21-7-6-19(25)14-23(21)28)8-5-17-15-26-10-9-20(17)16-3-2-4-18(24)13-16;/h2-10,13-15H,11-12H2,1H3;1H/b8-5+;.
What are the key properties of 8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride?
8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride has a molecular weight of 533.70 g/mol, XLogP of 6.65, 3 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 8-bromo-5-[(E)-2-[4-(3-bromophenyl)-3-pyridinyl]ethenyl]-1-methyl-2,3-dihydro-1,4-benzodiazepine;hydrochloride is sourced from PubChem (CID 162319307), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).